Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:545-552
Published online before print January 14, 2008, doi: 10.1161/CIRCULATIONAHA.107.710434
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
117/4/545    most recent
CIRCULATIONAHA.107.710434v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Taniike, M.
Right arrow Articles by Otsu, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taniike, M.
Right arrow Articles by Otsu, K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
Related Collections
Right arrow Hypertrophy
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice
Right arrowRelated Article

(Circulation. 2008;117:545-552.)
© 2008 American Heart Association, Inc.


Molecular Cardiology

Apoptosis Signal-Regulating Kinase 1/p38 Signaling Pathway Negatively Regulates Physiological Hypertrophy

Masayuki Taniike, MD; Osamu Yamaguchi, MD, PhD; Ikuko Tsujimoto, DDS, PhD; Shungo Hikoso, MD, PhD; Toshihiro Takeda, MD, PhD; Atsuko Nakai, MS; Shigemiki Omiya, MD; Isamu Mizote, MD; Yuko Nakano, DDS; Yoshiharu Higuchi, MD, PhD; Yasushi Matsumura, MD, PhD; Kazuhiko Nishida, MD, PhD; Hidenori Ichijo, PhD; Masatsugu Hori, MD, PhD; Kinya Otsu, MD, PhD

From the Departments of Cardiovascular Medicine (M.T., O.Y., S.H., T.T., A.N., S.O., I.M., Y.H., K.N., M.H., K.O.) and Medical Information Science (Y.M.), Graduate School of Medicine and First Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry (I.T., Y.N.), Osaka University, Osaka; and Laboratory of Cell Signaling, Graduate School of Pharmaceutical Science, University of Tokyo, Tokyo (H.I.), Japan.

Correspondence to Kinya Otsu, MD, PhD, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail kotsu{at}medone.med.osaka-u.ac.jp

Received April 19, 2007; accepted November 2, 2007.

Background— Mechanical stress on the heart can lead to crucially different outcomes. Physiological stimuli such as exercise cause adaptive cardiac hypertrophy, characterized by a normal cardiac structure and normal or enhanced cardiac function. Pathological stimuli such as hypertension and aortic valvular stenosis cause maladaptive cardiac remodeling and ultimately heart failure. Apoptosis signal-regulating kinase 1 (ASK1) is known to be involved in pathological cardiac remodeling, but it has not been determined whether ASK1 pathways coordinate the signaling cascade leading to physiological type cardiac growth.

Methods and Results— To evaluate the role of ASK1 in the physiological form of cardiac growth, mice lacking ASK1 (ASK1–/–) were exercised by swimming for 4 weeks. ASK1–/– mice showed exaggerated growth of the heart accompanied by typical characteristics of physiological hypertrophy. Their swimming-induced activation of Akt, a key molecule in the signaling cascade of physiological hypertrophy, increased more than that seen in wild-type controls. The activation of p38, a downstream kinase of ASK1, was suppressed selectively in the swimming-exercised ASK1–/– mice. Furthermore, the inhibition of ASK1 or p38 activity enhanced insulin-like growth factor 1–induced protein synthesis in rat neonatal ventricular cardiomyocytes, and the treatment with a specific inhibitor of p38 resulted in enhancement of Akt activation and suppression of protein phosphatase 2A activation. The cardiac-specific p38{alpha}-deficient mice developed an exacerbated form of cardiac hypertrophy in response to swimming exercise.

Conclusions— These results indicate that the ASK1/p38 signaling pathway negatively regulates physiological hypertrophy.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 453-455. [Full Text]